PTC Therapeutics
PTCT
#3053
Rank
โ‚น505.05 B
Marketcap
โ‚น6,051
Share price
-1.06%
Change (1 day)
5.61%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2026 (TTM): -โ‚น5.51 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are โ‚น1.00 Billion. In 2025 the company made an earning of โ‚น67.38 Billion, an increase over its 2024 earnings that were of -โ‚น35.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น5.51 Billion-108.17%
2025 โ‚น67.38 B-291.84%
2024 -โ‚น35.13 Billion-47.84%
2023 -โ‚น67.34 Billion18.49%
2022 -โ‚น56.83 Billion13.34%
2021 -โ‚น50.14 Billion28.64%
2020 -โ‚น38.98 Billion67.94%
2019 -โ‚น23.21 Billion87.28%
2018 -โ‚น12.4 Billion64.95%
2017 -โ‚น7.52 Billion-45.13%
2016 -โ‚น13.7 Billion-16.72%
2015 -โ‚น16.45 Billion72.64%
2014 -โ‚น9.53 Billion90.89%
2013 -โ‚น4.99 Billion96.58%
2012 -โ‚น2.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.501 T-23,241.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚น487.89 B-7,619.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น15.56 Billion 139.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น12.67 Billion 95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-โ‚น12.93 Billion 99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น66.23 Billion 920.71%๐Ÿ‡บ๐Ÿ‡ธ USA